4.8 Article

Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles

期刊

GUT
卷 59, 期 11, 页码 1457-1464

出版社

B M J PUBLISHING GROUP
DOI: 10.1136/gut.2009.205724

关键词

-

资金

  1. Japan Society for the Promotion of Science (JSPS) [17109013, 21229015]
  2. CREST, Japan Science and Technology Agency (JST)
  3. NEDO (New Energy and Industrial Technology Development Organization) Technological Development for Chromosome Analysis
  4. Ministry of Education, Culture, Sports, Science, and Technology of Japan for Scientific Research on Priority Areas, Cancer Translational Research Project, Japan
  5. Japan Science and Technology Agency, New Energy and Industrial Technology Development Organization
  6. Grants-in-Aid for Scientific Research [17109013, 21592014] Funding Source: KAKEN

向作者/读者索取更多资源

Background Oesophageal squamous cell carcinoma (OSCC) is considered a difficult cancer to cure. The detection of environmental and genetic factors is important for prevention on an individual basis. Objective To identify groups at high risk for OSCC by simultaneously analysing both genetic and environmental risk factors. Methods A multistage genome-wide association study of OSCC in Japanese individuals with a total of 1071 cases and 2762 controls was performed. Results Two associated single-nucleotide polymorphisms (SNPs), as well as smoking and alcohol consumption, were evaluated as genetic and environmental risk factors, respectively, and their interactions were also evaluated. Risk alleles of rs1229984 (ADH1B) and rs671 (ALDH2) were highly associated with OSCC (odds ratio (OR)=4.08, p=4.4 x 10(-40) and OR=4.13, p=8.4 x 10(-76), respectively). Also, smoking and alcohol consumption were identified as risk factors for OSCC development. By integrating both genetic and environmental risk factors, it was shown that the combination of rs1229984 and rs671 risk alleles with smoking and alcohol consumption was associated with OSCC. Compared with subjects with no more than one environmental or genetic risk factor, the OR reached 146.4 (95% CI 50.5 to 424.5) when both environmental and genetic risk factors were present. Without the genetic risks, alcohol consumption did not correlate with OSCC. In people with one or two genetic risk factors, the combination of alcohol consumption and smoking increased OSCC risk. Conclusions Analysis of ADH1B and ALDH2 variants is valuable for secondary prevention of OSCC in high-risk patients who smoke and drink alcohol. In this study, SNP genotyping demonstrated that the ADH1B and/or ALDH2 risk alleles had an interaction with smoking and, especially, alcohol consumption. These findings, if replicated in other groups, could demonstrate new pathophysiological pathways for the development of OSCC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma

Shinya Kidogami, Tomohiro Iguchi, Kuniaki Sato, Yukihiro Yoshikawa, Quingjang Hu, Sho Nambara, Hisateru Komatsu, Masami Ueda, Yosuke Kuroda, Takaaki Masuda, Masaki Mori, Yuichiro Doki, Koshi Mimori

ANTICANCER RESEARCH (2020)

Article Oncology

Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer

Shuhei Ito, Takaaki Masuda, Miwa Noda, Qingjiang Hu, Dai Shimizu, Yosuke Kuroda, Hidetoshi Eguchi, Taro Tobo, Tohru Utsunomiya, Koshi Mimori

ONCOLOGY (2020)

Article Multidisciplinary Sciences

A unified simulation model for understanding the diversity of cancer evolution

Atsushi Niida, Takanori Hasegawa, Hideki Innan, Tatsuhiro Shibata, Koshi Mimori, Satoru Miyano

Article Multidisciplinary Sciences

YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma

Hirofumi Omori, Miki Nishio, Muneyuki Masuda, Yosuke Miyachi, Fumihito Ueda, Takafumi Nakano, Kuniaki Sato, Koshi Mimori, Kenichi Taguchi, Hiroki Hikasa, Hiroshi Nishina, Hironori Tashiro, Tohru Kiyono, Tak Wah Mak, Kazuwa Nakao, Takashi Nakagawa, Tomohiko Maehama, Akira Suzuki

SCIENCE ADVANCES (2020)

Article Genetics & Heredity

Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases

Shotaro Sakimura, Satoshi Nagayama, Mitsuko Fukunaga, Qingjiang Hu, Akihiro Kitagawa, Yuta Kobayashi, Takanori Hasegawa, Miwa Noda, Yuta Kouyama, Dai Shimizu, Tomoko Saito, Atsushi Niida, Yusuke Tsuruda, Hajime Otsu, Yoshihiro Matsumoto, Hiroki Uchida, Takaaki Masuda, Keishi Sugimachi, Shin Sasaki, Kazutaka Yamada, Kazuki Takahashi, Hideki Innan, Yutaka Suzuki, Hiromi Nakamura, Yasushi Totoki, Shinichi Mizuno, Masanobu Ohshima, Tatsuhiro Shibata, Koshi Mimori

Summary: This study revealed the significant role of copy number aberrations in cancer evolution, as well as the importance of neoantigens and diverse T cell receptor repertoire in postoperative recurrence. The comparison of driver mutations and immune response-related molecules between early and metastatic sites showed differences, and the postoperative recurrence was associated with neoantigen levels and TCR diversity in the metastatic sites.

PLOS GENETICS (2021)

Article Oncology

The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer

Atsushi Fujii, Takaaki Masuda, Michio Iwata, Taro Tobo, Hiroaki Wakiyama, Kensuke Koike, Keisuke Kosai, Takafumi Nakano, Shotaro Kuramitsu, Akihiro Kitagawa, Kuniaki Sato, Yuta Kouyama, Dai Shimizu, Yoshihiro Matsumoto, Tohru Utsunomiya, Takao Ohtsuka, Yoshihiro Yamanishi, Masafumi Nakamura, Koshi Mimori

Summary: The study identified ASAP2 as a novel driver gene in PDAC, with high expression contributing to a poor prognosis and promoting tumor growth by facilitating cell cycle progression. Niclosamide, repositioned as a drug targeting the ASAP2 pathway, suppresses PDAC growth by inhibiting ASAP2 expression.

CANCER SCIENCE (2021)

Article Oncology

The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy

Hidenari Hirata, Atsushi Niida, Nobuyuki Kakiuchi, Ryutaro Uchi, Keishi Sugimachi, Takaaki Masuda, Tomoko Saito, Shun-Ichiro Kageyama, Yushi Motomura, Shuhei Ito, Tadamasa Yoshitake, Daisuke Tsurumaru, Yusuke Nishimuta, Akira Yokoyama, Takanori Hasegawa, Kenichi Chiba, Yuichi Shiraishi, Junyan Du, Fumihito Miura, Masaru Morita, Yasushi Toh, Masakazu Hirakawa, Yoshiyuki Shioyama, Takashi Ito, Tetsuo Akimoto, Satoru Miyano, Tatsuhiro Shibata, Masaki Mori, Yutaka Suzuki, Seishi Ogawa, Kousei Ishigami, Koshi Mimori

Summary: A study sequencing 52 tumor samples from 33 ESCC patients who received radiotherapy combined with 5-fluorouracil/platinum revealed the impact of chemoradiotherapy on clonal evolution, with MYC gain potentially serving as a marker for therapy resistance. The findings enhance understanding of therapeutic resistance and support the rationale for precision chemoradiotherapy.

CANCER RESEARCH (2021)

Article Oncology

Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA

Kuniko Sunami, Hideaki Bando, Yasushi Yatabe, Yoichi Naito, Hideaki Takahashi, Katsuya Tsuchihara, Shinichi Toyooka, Koshi Mimori, Shinji Kohsaka, Hiroyuki Uetake, Ichiro Kinoshita, Keigo Komine, Masayuki Takeda, Tetsu Hayashida, Kenji Tamura, Kazuto Nishio, Noboru Yamamoto

Summary: Comprehensive genomic profiling (CGP) is increasingly used in Japan for the clinical management of solid cancers, with some restrictions such as patient eligibility and opportunities for testing. The implementation of CGP based on plasma circulating tumor DNA (ctDNA) may raise issues regarding the selection and use of tissue DNA and ctDNA CGP.

CANCER SCIENCE (2021)

Article Oncology

Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy

Takaaki Masuda, Osamu Niizeki, Takashi Niizeki, Kenji Fujiyoshi, Yuki Ando, Hiroshi Niizeki, Koshi Mimori

Summary: This case describes a MBC patient with predominant liver metastases who declined systemic therapy and opted for hepatic arterial infusion chemotherapy (HAIC), showing partial response or stable disease in the liver and slow progression in other sites, surviving for 1 year and 3 months. The study suggests that HAIC may be a therapeutic option for advanced breast cancer patients with liver metastases who cannot tolerate systemic therapy.

CASE REPORTS IN ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Identification of serum microRNAs as potential diagnostic biomarkers for detecting precancerous lesions of gastric cancer

Hajime Otsu, Sho Nambara, Qingjiang Hu, Yuichi Hisamatsu, Takeo Toshima, Kazuki Takeishi, Yusuke Yonemura, Takaaki Masuda, Eiji Oki, Koshi Mimori

Summary: The study aimed to identify individuals at high risk of gastric cancer by detecting microRNAs (miRNA) in the blood as biomarkers. Specific miRNA combinations may serve as promising biomarkers for precancerous lesions in gastric cancer.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2023)

Article Multidisciplinary Sciences

Mutated genes on ctDNA detecting postoperative recurrence presented reduced neoantigens in primary tumors in colorectal cancer cases

Satoshi Nagayama, Yuta Kobayashi, Mitsuko Fukunaga, Shotaro Sakimura, Keishi Sugimachi, Shin Sasaki, Takaaki Masuda, Ken-ichi Mafune, Masanobu Oshima, Tatsuhiro Shibata, Yutaka Suzuki, Koshi Mimori

Summary: The detection and sequencing of mutated ctDNA is essential in postoperative management of colorectal cancer (CRC). This study conducted target resequencing of ctDNA and found that mutated genes in ctDNA indicated immune-resistance traits due to the loss of neoantigen presentation in primary CRC tumors. Therefore, ctDNA mutations can be frequently detected postoperatively to identify recurrence, but they come from immune-tolerated clones.

SCIENTIFIC REPORTS (2023)

Article Cell Biology

Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G plus cancer cells and SPP1+macrophages in colorectal cancer

Yuki Ozato, Yasuhiro Kojima, Yuta Kobayashi, Yuuichi Hisamatsu, Takeo Toshima, Yusuke Yonemura, Takaaki Masuda, Kouichi Kagawa, Yasuhiro Goto, Mitsuaki Utou, Mituko Fukunaga, Ayako Gamachi, Kiyomi Imamura, Yuta Kuze, Junko Zenkoh, Ayako Suzuki, Atsushi Niida, Haruka Hirose, Shuto Hayashi, Jun Koseki, Eiji Oki, Satoshi Fukuchi, Kazunari Murakami, Taro Tobo, Satoshi Nagayama, Mamoru Uemura, Takeharu Sakamoto, Masanobu Oshima, Yuichiro Doki, Hidetoshi Eguchi, Masaki Mori, Takeshi Iwasaki, Yoshinao Oda, Tatsuhiro Shibata, Yutaka Suzuki, Teppei Shimamura, Koshi Mimori

Summary: The cellular interactions in the tumor microenvironment of colorectal cancer (CRC) remain poorly understood. This study investigates the importance of events occurring at the invasion front for CRC treatment strategies. The findings highlight the signaling between CRC cell populations and stromal cell populations, specifically at the invasion front.

CELL REPORTS (2023)

Review Gastroenterology & Hepatology

The comprehensive review of gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) from diagnosis and treatment

Masaaki Iwatsuki, Chihiro Matsumoto, Koshi Mimori, Hideo Baba

Summary: Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) is a rare familial gastric cancer syndrome caused by a mutation in the APC gene. Treatment involves standard methods for gastric cancer, with prognosis depending on the presence of distant metastasis and the use of total gastrectomy. Prophylactic total gastrectomy is recommended in cases of dysplasia, but careful consideration of the patient's background is necessary. Currently, there are no guidelines for screening, timing of prophylactic total gastrectomy, or endoscopic surveillance for GAPPS.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2023)

Editorial Material Gastroenterology & Hepatology

Novel and classic approaches for managing gastrointestinal cancers

Koshi Mimori

ANNALS OF GASTROENTEROLOGICAL SURGERY (2023)

Article Oncology

Trousseau's Syndrome with Advanced Neuroendocrine Carcinoma of Colon: A Case Report

Hirofumi Ohmura, Taro Tobo, Koshi Mimori, Eishi Baba, Takahiko Horiuchi

Summary: We report a case of colon neuroendocrine carcinoma (NEC) that developed Trousseau's syndrome. The patient experienced disease progression after multiple lines of therapy and ultimately died due to worsening condition.

CASE REPORTS IN ONCOLOGY (2023)

暂无数据